Condition

Lung Cancer, Small Cell

ClinicalTrials.gov condition label

Clinical trials23

Recruiting3

Common interventions25

Lead sponsors shown14

Clinical trials

23 shown

Engagement of Veterans With Lung CancerNCT07219251 · 2026-02-27

Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and CarboplatinNCT06698965 · 2024-10-13

A Study on the Efficacy of Atezolizumab Combined with ChemotherapyNCT06780826 · 2024-08-28

Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction TherapyNCT06914050 · 2025-04-01

NOT_YET_RECRUITING

The Diagnostic Value of Bronchoscopic Needle-based Confocal Laser Endomicroscopy (nCLE) As a Real-time Detection Tool for Diagnosing Peripheral Lung Cancer: a Multi-centre Randomised Controlled TrialNCT06739421 · 2025-01-01

NOT_YET_RECRUITING

Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scanNCT06293833 · 2024-09-01

Pulmonary Rehabılıtatıon Wıth Non-Small Lung CancerNCT05320458 · 2022-05-02

A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLCNCT05228496 · 2022-03-17

Trial of NanoPac Intratumoral Injection in Lung CancerNCT04314895 · 2021-04-14

CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsNCT04660929 · 2021-02-02

NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung CancerNCT04986670 · 2020-11-24

ACTIVE_NOT_RECRUITING

Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer TreatmentNCT04440800 · 2020-07-01

Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNANCT03499678 · 2018-07-01

A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) PopulationNCT01313663 · 2011-02-01

Regulatory Hycamtin(Oral) PMSNCT01037023 · 2010-10-01

SCOT Registry: Small Cell Lung Cancer Treatment and OutcomeNCT00997061 · 2009-11-01

Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung CancerNCT00698516 · 2008-07-01

First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And ParaplatinNCT00316186 · 2005-06-01

A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid TumorsNCT00259935 · 2004-10-04

The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)NCT00043862 · 2002-08-01

Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung CancerNCT00320359 · 2002-08-01

A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid TumorsNCT00046111 · 2001-09-01

Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung CancerNCT00276276 · 2000-11-01

Common interventions

Leading sponsors

GlaxoSmithKline10 Carisma Therapeutics Inc1 China-Japan Friendship Hospital1 Hasan Kalyoncu University1 HKGepitherapeutics1 NanOlogy, LLC1 Palo Alto Veterans Institute for Research1 Royal Marsden NHS Foundation Trust1 Shanghai Chest Hospital1 Shanghai Pulmonary Hospital, Shanghai, China1 Tianjin Medical University Cancer Institute and Hospital1 Tufts University1 University Hospital, Antwerp1 Zhejiang Cancer Hospital1

Trial status mix

COMPLETED10

UNKNOWN5

RECRUITING3

NOT_YET_RECRUITING2

TERMINATED2

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE28

NA5

PHASE13

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.